Buffalo Elmiron Injury
Jed Dietrich, Esq., Renowned as a New York Super Lawyer and American Institute of Personal Injury Attorneys 10 Best Attorneys, and His Team of Tenacious and Dedicated Lawyers at the Dietrich Law Firm P.C., Celebrated as a Best Law Firm of America, Litigate to Obtain Unbeatable Results for Victims Who Have Suffered Pigmentary Maculopathy Caused by Taking Elmiron in Buffalo, New York.
Pentosan polysulfate sodium (PPS), widely known as Elmiron, was initially designated as an orphan drug under the United States Food and Drug Administration’s (FDA) Orphan Drug Act (ODA). The act bestows special status to medications used to treat rare diseases or conditions. In 1996, after numerous denials, Elmiron received full approval from the Food and Drug Administration for the treatment of bladder pain or discomfort accompanying interstitial cystitis (IC). Generally, patients struggling with interstitial cystitis experience various symptoms, such as an abrupt urge to urinate, penetrating pelvic pain, frequent urination of small amounts (up to 75 times each day), and tenderness throughout intercourse.
Elmiron is the only oral drug officially approved for treating the aggravation and irritation associated with interstitial cystitis, commonly referred to as painful bladder syndrome. While scientists do not know exactly how Elmiron works, they believe the drug coats the bladder and protects it from irritants in urine. However, Elmiron’s active ingredient has been linked to unique pigmentary maculopathy, an irreversible type of retinal damage. The retina is responsible for sensing light, ensuring the clarity of images, and directing signals essential for vision to the brain. Recent research revealed that roughly 1 in 4 patients who had been prescribed Elmiron long-term demonstrated some vision loss. Suppose you, or someone close to you, were unfortunate enough to suffer from retinal damage or vision loss caused by Elmiron; you owe it to yourself to retain an elite product liability attorney.
Jed Dietrich, Esq., an eminent member of the Million Dollar Advocates Forum, and his team of Buffalo, New York Elmiron-related macular degeneration lawyers at the Dietrich Law Firm P.C. have helped thousands of clients to obtain the justice that they deserve. With over 22 years of providing the best possible legal representation to victims who need it the most, Jed Dietrich, Esq. has the expertise and verified results to demand the compensation that you so desperately need. You can trust the Dietrich Law Firm P.C.’s veteran attorneys to be with you every step of the way. Our highly experienced lawyers are here to help you through this challenging time and will treat you with the kindness and admiration that you deserve. Insurance companies have paid Jed Dietrich, Esq. more than $175,000,000.00 in verdicts and settlements to resolve personal injury claims. There is no time like the present to contact our highly experienced law firm at (716) 839-3939 or by filling out the online consultation form. Our best of the best team is available 24 hours per day and 7 days per week, and there is never a fee unless we WIN for you!Current Lawsuits Against Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, is responsible for the manufacturing and marketing of Elmiron. In 2015, ophthalmologists found that a majority of patients receiving treatment for pigmentary maculopathy had been prescribed Elmiron. Research later determined that Elmiron’s active ingredient was toxic to patients’ retinal tissues. However, Janssen recklessly failed to warn doctors and patients alike. It took the company roughly 24 years after the approval of its drug to update the warning label. Throughout the years, millions of unsuspecting victims have been irresponsibly exposed to Elmiron’s retina damage-causing toxicity.
Janssen Pharmaceuticals was legally obligated to ensure that its interstitial cystitis medication did not harm those who took it. Consequently, victims who have taken the drug and been diagnosed with eye damage or vision loss are actively filing lawsuits. On December 15, 2020, the United States Judicial Panel on Multidistrict Litigation ordered all Elmiron cases to be consolidated in the District of New Jersey. Judge Brian R. Martinotti is currently overseeing the multidistrict litigation (MDL) involving approximately 240 Elmiron lawsuits. The first bellwether trial in the multidistrict litigation is expected to be held around January 2023, with ensuing bellwether trials to follow. The Dietrich Law Firm P.C.’s battle-tested team has been closely tracking the ongoing litigation against Janssen. Jed Dietrich, Esq. has tried over 100 cases to verdict in the New York State Supreme Court. Our award-winning trial attorneys are available if you would like to learn more about Elmiron lawsuits and your legal options.
WERE YOU, OR A LOVED ONE, DIAGNOSED WITH EYE DAMAGE OR VISION
LOSS AFTER BEING PRESCRIBED ELMIRON IN BUFFALO,
CHEEKTOWAGA, TONAWANDA, WEST SENECA, OR
OTHER PARTS OF NEW YORK STATE?
CONTACT JED DIETRICH, ESQ. AND HIS TOP RATED AND HIGHLY SKILLED
TEAM OF BUFFALO, NEW YORK ELMIRON EYE INJURY ATTORNEYS AT
(716) 839-3939 NOW TO RETAIN THE HELP THAT YOU DESERVE!
Buffalonians suffering from macular degeneration are fortunate enough to have some of the country’s best ophthalmologists available for diagnosis and treatment. Although there is still no cure, several vision therapies and low-vision devices can help build your visual skills, develop innovative ways to perform activities, and adjust to living with macular degeneration. High levels of vascular endothelial growth factor (VEGF) in the eye are connected to the development of abnormal blood vessels that cause much of the damage. Injections of anti-vascular endothelial growth factors are used to destroy the formation of these blood vessels and reduce the damaging effect. These injections can effectively stabilize vision and even improve your visual acuity. Medications, such as Eylea, Lucentis, Avastin, or Macugen, are injected directly into the eye with a very fine needle. Laser therapy is also commonly used to help destroy abnormal blood vessels. If necessary, low vision devices can be used to generate larger images of objects and assist patients suffering from macular degeneration-related vision loss to make the most of their eyesight. An ophthalmologist can determine the best available treatments based on your particular needs.
Although no amount of money can undo your eye damage, you may be eligible to receive monetary compensation for expenses associated with medical treatments, including hospitalizations, emergency services, diagnostic and imaging tests, surgical procedures, and all other treatments. Additionally, depending on your circumstances, our elite defective drug attorneys can seek damages for lost wages from missing work, reduced earning capacity, permanent disability, pain and suffering, loss of consortium, and all other unanticipated expenses. Jed Dietrich, Esq., selected as a Top 3 Personal Injury Lawyer in Buffalo, New York, will not allow Janssen’s carelessness to ruin your life. You can count on the Dietrich Law Firm P.C.’s veteran team to zealously battle to obtain the best possible result for your vision loss. Jed Dietrich, Esq. and his leading team would be pleased to discuss your potential lawsuit in further detail. Our seasoned team is available twenty-four-seven by calling (716) 839-3939 or by completing the online consultation form. Hire our top rated personal injury lawyers to demand the compensation that you deserve today!
Call the Dietrich Law Firm P.C. immediately at (716) 839-3939 so that our aggressive, tenacious and hardworking personal injury lawyers can fight to obtain the best result for your personal injury claim in Buffalo, New York. We are available 24 hours a day, 7 days a week, and there is never a fee until we WIN for you!